The Globe and Mail reports in its Friday, Sept. 15, edition that Laurentian Bank of Canada's decision to not proceed with a sale of the company did not come as a surprise to the Street, but some analysts have dropped their price targets now that the path forward is more clear. The Globe's Darcy Keith writes in the Eye On Equities column that CIBC World Markets slashed its share target by $17 to $37, as well, lowering its rating to "neutral" from "outperformer" -- which reverts back to where its target and rating stood prior to Laurentian Bank's strategic review. RBC Capital RBC downgraded its rating to "underperform" and cut its share target to $33 from $39. Barclays cut its share target to $32 from $42. Scotia analyst Meny Grauman's share target remains the same at $38, with an unchanged "sector perform" recommendation. Mr. Grauman says in a note: "This caps off a sale process/strategic review that the market first learned about from an article in the Globe & Mail after market close on July 11, 2023. We view this announcement as neutral because over the past few weeks it has largely become the consensus view, and is now almost fully reflected in the shares current valuation."